Molecular Screening for Hepatitis Virus

HBV can cause acute and chronic infection. There is currently no role for molecular testing in the diagnosis of acute hepatitis B other than in the detection of asymptomatic patients during pretransfusion screening of blood products. To facilitate an understanding of the utility of molecular testing for chronic hepatitis B, the four stages of chronic hepatitis B infection that are currently recognized, as well as an additional entity, occult hepatitis B, that can be diagnosed only by sensitive nucleic acid amplification methods, are reviewed in detail, including available therapeutic age

  • Serological and molecular testing
  • Laboratory methods for Diagnosis & management
  • Current molecular methods

  • Serological
  • Laboratory methods for Diagnosis & management
  • Molecular testing

Related Conference of Molecular Screening for Hepatitis Virus

November 21-22, 2024

23rd World Congress on Gastrointestinal Cancer

Dubai, UAE
March 10-11, 2025

8th International Congress on Viral Hepatitis

Paris, France
March 13-14, 2025

13th International Conference on Gynecology and Obstetrics

Prague, Czech Republic
August 21-22, 2025

6th Global Summit on Earth Science and Climate Change

Aix-en-Provence, France

Molecular Screening for Hepatitis Virus Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in